The Enterprise Value as of November 2024 (TTM) for Galectin Therapeutics Inc. (GALT) is 251.97M

According to Galectin Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 251.97M. This represents a change of 22.63% compared to the average of 205.47M of the last 4 quarters.

Galectin Therapeutics Inc. (GALT) Historical Enterprise Value (quarterly & annually)

How has GALT Enterprise Value performed in the past?

The mean historical Enterprise Value of Galectin Therapeutics Inc. over the last ten years is 86.38M. The current 251.97M Enterprise Value has changed 29.07% with respect to the historical average. Over the past ten years (40 quarters), GALT's Enterprise Value was at its highest in in the September 2024 quarter at 248.76M. The Enterprise Value was at its lowest in in the December 2015 quarter at 13.17M.

Galectin Therapeutics Inc. (GALT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Galectin Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Galectin Therapeutics Inc. (GALT) Average Enterprise Value

How has GALT Enterprise Value performed in the past?

The current Enterprise Value of Galectin Therapeutics Inc. (GALT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Galectin Therapeutics Inc. (GALT) Enterprise Value vs. Peers

How is GALT’s Enterprise Value compared to its peers?

Galectin Therapeutics Inc.’s Enterprise Value is less than Madrigal Pharmaceuticals, Inc. (7.46B), less than Viking Therapeutics, Inc. (5.81B), less than Sarepta Therapeutics, Inc. (12.11B), greater than Hepion Pharmaceuticals, Inc. (5.35M), less than PTC Therapeutics, Inc. (3.21B), less than Intercept Pharmaceuticals, Inc. (915.81M), greater than Terns Pharmaceuticals, Inc. (222.97M), less than Akero Therapeutics, Inc. (2.00B), less than Reata Pharmaceuticals, Inc. (6.64B), greater than DiaMedica Therapeutics Inc. (197.21M), greater than Milestone Pharmaceuticals Inc. (139.34M), greater than Seres Therapeutics, Inc. (158.02M), greater than Inhibikase Therapeutics, Inc. (154.45M), greater than Oncolytics Biotech Inc. (84.27M), less than 89bio, Inc. (940.63M), less than Pliant Therapeutics, Inc. (770.48M), less than Arcellx, Inc. (4.79B), less than Stoke Therapeutics, Inc. (457.69M),

Build a custom stock screener for Galectin Therapeutics Inc. (GALT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galectin Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Galectin Therapeutics Inc. (GALT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Galectin Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.